A new partnership begins with Aruvant Sciences

INNOVHEM is very pleased to announce a new partnership! We will be working with Aruvant Sciences to support the development of ARU-1801, a gene therapy for Sickle Cell Disease, INNOVHEM is proud to be a part of this endeavour to cure Sickle Cell Disease

!